UK firm Provexis has filed to demerge the Science in Sport (SiS) consumer sports brand it purchased for €10m in June 2011 from its Fruitflow tomato-based ingredients business, as it believes the separation will increase the market value and perception...
Krill oil producer Neptune Technologies and Bioressources has been slapped with two additional class action shareholders’ rights lawsuits and another two law firms have announced investigations into whether the company has violated securities laws.
Neptune Technologies and Bioressources has been hit with a shareholder rights lawsuit over the Nov. 8 explosion and fire that destroyed the company’s production facility and a resulting steep decline in the company’s share price.
The consumer arm of German pharma giant Bayer Healthcare is to pay $1.2bn (€920m) for US food supplements company Schiff Nutrition International, a move that will make it one of the biggest operators there, feed product development globally, and may not...
US chemical group DuPont has successfully completed its tender offer for Danisco, as 92.2 percent of outstanding shares in the Danish food ingredients firm were tendered by Friday’s deadline, DuPont said on Monday.
Elliott International has increased its Danisco shareholding to 10.01 per cent and has not yet given any indication of tender plans, despite the Friday deadline for 80 per cent of shares to be tendered in order for the deal to go through.
Royal DSM’s acquisition of Martek Biosciences Corporation has moved a step closer to finalisation with the news that its tender offer to buy all of the company’s outstanding shares of common stock at a price of $31.50 (about €24) per share has proved...
Danisco is to be snapped up by DuPont for $6.3bn, in a deal Dupont says could create a global leader in industrial biotech – and help drive science-based solutions to the world’s food and fuel challenges.
Regulating food speculation in the City of London is the lynchpin to preventing volatility over food prices, say economists, as parallel measures on both sides of the Atlantic will block traders conducting secretive deals wherever they can.
As Danone’s share price continues to fall three days after its half year results were released, the company cites several potential reasons for the dip but insists that health claims uncertainty is not among them.
UK-based start-up Provexis has signed a Letter of Intent with its biggest shareholder, DSM, that will give the nutritional products division of the Dutch company exclusive global rights to Provexis’s tomato extract Fruitflow technology.
Reports of my death have been greatly exaggerated, quipped Mark Twain. Predictions of the demise of Cadbury following the approval of Kraft’s offer are premature and are flawed by knee-jerk anti-Americanism.
Rumour, according to the Romans, is a feathered beast with a myriad eyes and tongues. Last week she went bristling through the Danish business pages, spreading the news that Danisco could be bought by a private equity firm.
Norwegian fish oil producer EPAX is to be acquired by compatriot
Austevoll Seafood - a move that will give it a vertically
integrated supply from fishing to omega-3 oil supply and avoid
potential sourcing problems for the future.
UK natural healthcare firm William Ransom said today that it will
buy Optima Healthcare, the UK market leader in aloe vera brands,
and its Irish subsidiary for £23 million (€34.3m), reports
DSM, the world's leading producer of vitamins, said yesterday that
operating profits in the first quarter would be significantly
better than previously forecast, at 40 per cent higher than in last
year's same period.
Management at the Royal Schouten group, parent of soy ingredients
business Acatris, has increased its share in the company under a
new shareholder structure designed to allow it to move more easily
on strategic developments, such...
Australian vitamin and drug maker Lipa Pharmaceuticals plans to
raise A$67 million (€38.2m) from an initial public offering of
shares, which will fund expansion of the company's manufacturing
plant to meet growing customer demand.
Hawaiian firm Cyanotech has yet again managed to stave off a
delisting from the Nasdaq SmallCap market, meeting requirements for
the bid price of $1 per share for a consecutive 10 days in recent